Daily Costs and Cost Effectiveness of Glaucoma Fixed Combinations in China
Background. The aim of this study was to compare the daily costs and cost effectiveness of fixed combination glaucoma drugs in China. Methods. This study included the following fixed combination drugs: brinzolamide 1% and timolol 0.5% (Azarga; Alcon, Inc., Fort Worth, TX, USA), travoprost 0.004% and...
Main Authors: | Chenjia Xu, Ruru Guo, Dandan Huang, Jian Ji, Wei Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2020/2406783 |
Similar Items
-
Identification and functional analysis of a novel missense mutation in GJA8, p.Ala69Thr
by: Dandan Li, et al.
Published: (2020-11-01) -
Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden
by: Anders Bergström, et al.
Published: (2009-08-01) -
Fixed combinations of glaucoma medications
by: Babić Nikola
Published: (2015-01-01) -
Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
by: Jianjun Tang, PhD, et al.
Published: (2019-07-01) -
Transscleral cyclophotocoagulation followed by cataract surgery: a novel protocol to treat refractory acute primary angle closure
by: Wei Liu, et al.
Published: (2020-05-01)